Table 5.
Quantification of sarcopenia and obesity in the BaSAlt cohort.
| Women (n = 49) | Men (n = 17) | |
|---|---|---|
| Sarcopenia | ||
| SARC-F | 3.2 (SD ± 2.6) | 2.6 (SD ± 2.5) |
| Risk of sarcopenia | 34.7% (n = 17) | 23.5% (n = 4) |
| No risk of sarcopenia | 49.0% (n = 24) | 64.7% (n = 11) |
| Hand force measurement | 13.6 (SD ± 5.1) | 23.8 (SD ± 6.3) |
| Quantified as sarcopenic | 57.1% (n = 28) | 70.6% (n = 12) |
| Quantified as non-sarcopenic | 40.8% (n = 20) | 23.5% (n = 4) |
| Appendicular skeletal muscle mass | 16.1 (SD ± 3.7) | 22.6 (SD ± 2.3) |
| Quantified as sarcopenic | 30.6% (n = 15) | 11.8% (n = 2) |
| Quantified as non-sarcopenic | 69.4% (n = 34) | 88.2% (n = 15) |
| 4-m walking speed test | 0.6 (SD ± 0.2) | 0.6 (SD ± 0.2) |
| Quantified as sarcopenic | 83.7% (n = 41) | 88.2% (n = 15) |
| Quantified as non-sarcopenic | 16.3% (n = 8) | 11.8% (n = 2) |
| Obesity | ||
| Body mass index | ||
| Quantified as obese | 14.3% (n = 7) | 29.4% (n = 5) |
| Quantified as non-obese | 85.7% (n = 42) | 70.6% (n = 12) |
| Fat mass in % | ||
| Quantified as obese | 8.2% (n = 4) | 29.4% (n = 5) |
| Quantified as non-obese | 91.8% (n = 45) | 70.6% (n = 12) |
| Fat mass index | ||
| Quantified as obese | 12.2% (n = 6) | 29.4% (n = 5) |
| Quantified as non-obese | 87.8% (n = 43) | 70.6% (n = 12) |